Brainsway Ltd (BWAY)

Currency in USD
15.25
+1.09(+7.70%)
Closed·
15.250.00(0.00%)
·
Earnings results expected in 12 days
BWAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.6515.47
52 wk Range
5.6817.35
Key Statistics
Prev. Close
14.16
Open
14.65
Day's Range
14.65-15.47
52 wk Range
5.68-17.35
Volume
82.21K
Average Volume (3m)
129.37K
1-Year Change
161.1301%
Book Value / Share
1.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BWAY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.67
Upside
+15.85%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Brainsway Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 17.67
(+15.85% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy17.00+11.48%-MaintainJul 24, 2026
BTIG
Buy18.00+18.03%-New CoverageJul 20, 2026
H.C. Wainwright
Buy14.00-8.20%-MaintainJul 17, 2026
H.C. Wainwright
Buy17.00+11.48%-MaintainJul 17, 2026
H.C. Wainwright
Buy17.00+11.48%-MaintainJul 02, 2026

Earnings

Latest Release
May 13, 2026
EPS / Forecast
0.06 / 0.03
Revenue / Forecast
15.5M / 14.31M
EPS Revisions
Last 90 days

BWAY Income Statement

Compare BWAY to Peers and Sector

Metrics to compare
BWAY
Peers
Sector
Relationship
P/E Ratio
70.6x−0.6x−0.3x
PEG Ratio
0.37−0.030.00
Price/Book
8.2x3.6x2.6x
Price / LTM Sales
11.0x3.3x3.0x
Upside (Analyst Target)
27.1%59.7%56.6%
Fair Value Upside
Unlock15.2%10.2%Unlock

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.09M12.70%72.09M
Other Institutional Investors
11.25M28.07%159.34M
Public Companies & Retail Investors
23.74M59.23%336.21M
Total
40.09M100.00%567.64M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Valor Management LLC13.26%5,314,95075,260
Masters Capital Management, L.L.C.4.12%1,650,00023,364

People Also Watch

13.47
FLNC
+13.29%
66.92
MXL
+16.89%
203.07
CBRS
+19.88%
46.940
AXTI
+26.97%
112.20
SPCX
-0.31%

FAQ

What Is the Brainsway (BWAY) Stock Price Today?

The Brainsway stock price today is 15.25 USD.

What Stock Exchange Does Brainsway Trade On?

Brainsway is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Brainsway?

The stock symbol for Brainsway is "BWAY."

What Is the Brainsway Market Cap?

As of today, Brainsway market cap is 618.53M USD.

What Is Brainsway's Earnings Per Share (TTM)?

The Brainsway EPS (TTM) is 0.22.

When Is the Next Brainsway Earnings Date?

Brainsway will release its next earnings report on Aug 12, 2026.

From a Technical Analysis Perspective, Is BWAY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Brainsway Stock Split?

Brainsway has split 1 times.

How Many Employees Does Brainsway Have?

Brainsway has 129 employees.

What is the current trading status of Brainsway (BWAY)?

As of Jul 31, 2026, Brainsway (BWAY) is trading at a price of 15.25 USD, with a previous close of 14.16 USD. The stock has fluctuated within a day range of 14.65 USD to 15.47 USD, while its 52-week range spans from 5.68 USD to 17.35 USD.

What Is Brainsway (BWAY) Price Target According to Analysts?

The average 12-month price target for Brainsway is 17.67 USD, with a high estimate of 18 USD and a low estimate of 17 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +15.85% Upside potential.

What Is the BWAY Premarket Price?

BWAY's last pre-market stock price is 14.85 USD. The pre-market share volume is 520.00, and the stock has decreased by 0.69, or 4.87%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.